CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...